Rhabdomyosarcoma: Molecular diagnostics of patients classified by morphology and immunohistochemistry with emphasis on bone marrow and purged peripheral blood progenitor cells involvement

Virchows Archiv

Volumn 448, Issue 4, 2006, Pages 449-458

  Krskova L ^a   Mrhalova M ^a   Sumerauer, D ^a   Kodet, R ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Bone marrow; Immunohistochemistry; Molecular diagnosis; Peripheral blood progenitor cells; Rhabdomyosarcoma; RT PCR

Indexed keywords

CHIMERIC PROTEIN; MYOD1 PROTEIN; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR PAX3; TRANSCRIPTION FACTOR PAX7;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW; CANCER RECURRENCE; CANCER SURGERY; CELL STRUCTURE; CHILD; CLINICAL ARTICLE; DIAGNOSTIC PROCEDURE; EMBRYO; FEMALE; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MALE; METASTASIS; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA; TUMOR CELL;

ADOLESCENT; BONE MARROW; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; MALE; MOLECULAR DIAGNOSTIC TECHNIQUES; MUSCLE NEOPLASMS; MYOD PROTEIN; NEOPLASM RECURRENCE, LOCAL; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA, ALVEOLAR; RHABDOMYOSARCOMA, EMBRYONAL; RNA, MESSENGER; RNA, NEOPLASM; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 33645558824     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-005-0124-y     Document Type: Article

References (49)

1. Afify A, Mark HF (1999) Trisomy 8 in embryonal rhabdomyosarcoma detected by fluorescence in situ hybridization. Cancer Genet Cytogenet 108:127-132
2. Anderson J, Gordon A, Pritchard-Jones K, Ship ley J (1999) Genes, chromosomes, and rhabdomyosarcoma. Genes Chromosomes Cancer 26:275-285
3. Barr FG (1997) Molecular genetics and pathogenesis of rhabdomyosarcoma. J Pediatr Hematol Oncol 19(6):483-491
4. Barr FG (1999) The role of chimeric paired box transcription factors in the pathogenesis of pediatric rhabdomyosarcoma. Cancer Res 59(7 Suppl):1711-1715
5. Bober E, Franz T, Arnold HH, Gruss P, Tremblay P (1994) PAX3 is required for the development of limb muscles: a possible role for the migration of dermomyotomal muscle progenitor cells. Development 120:603-612
6. Cessna MH, Zhou H, Perkins SL, Tripp SR, Pickering D, Daines C, Coffin CM (2001) Are myogenin and MyoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics. Am J Surg Pathol 25:1150-1157
7. Chen B, Dias P, Jenkins JJ III, Savell VH, Parham DM (1998) Methylation alterations of the MyoD1 upstream region are predictive of subclassification of human rhabdomyosarcomas. Am J Pathol 152(4):1071-1079
8. Coffin CM, Rulon J, Smith L, Bruggers C, White FV (1997) Pathologic features of rhabdomyosarcoma before and after treatment: a clinicopathologic and immunohistochemical analysis. Mod Pathol 10:1175-1187
9. d'Amore ES, Tollot M, Stracca-Pansa V, Menegon A, Meli S, Carli M, Ninfo V (1994) Therapy associated differentiation in rhabdomyosarcomas. Mod Pathol 7:69-75
10. Davis RJ, Barr FG (1997) Fusion genes resulting from alternative chromosomal translocations are overexpressed by gene-specific mechanisms in alveolar rhabdomyosarcoma. Proc Natl Acad Sci U S A 94:8047-8051
11. Davis RJ, D'Cruz CM, Lovell MA, Biegel JA, Barr FG (1994) Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. Cancer Res 54 (11):2869-2872
12. Davis RL, Weintraub H, Lassar AB (1987) Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51(6):987-1000
13. Dias P, Chen B, Dilday B, Palmer H, Hosoi H, Singh S, Wu C, Li X, Thompson J, Parham D, Qualman S, Houghton P (2000) Strong immunostaining for myogenin in rhabdomyosarcoma is significantly associated with tumors of the alveolar subclass. Am J Pathol 2:399-408
14. Douglass EC, Valentine M, Etcubanas E, Paraham D, Webber BL, Houghton PJ, Houghton JA, Green AA (1987) A specific chromosomal abnormality in rhabdomyosarcoma. Cytogenet Cell Genet 45:148-155
15. Douglass EC, Rowe ST, Valentine M, Paraham DM, Berkow R, Bowman WP, Maurer HM (1991) Variant translocations of chromosome 13 in alveolar rhabdomyosarcoma. Genes Chromosomes Cancer 3(6):480-482
16. Douglass EC, Shapiro DN, Valentine M, Rowe ST, Carroll AJ, Raney RB, Ragab AH, Abella SM, Paraham DM (1993) Alveolar rhabdomyosarcoma with the t(2;13): cytogenetic findings and clinicopathologic correlations. Med Pediatr Oncol 21:83-87
17. Downing JR, Khandekar A, Shurtleff SA, Head DR, Paraham DM, Webber BL, Pappo AS, Hulshof MG, Conn WP, Shapiro DN (1995) Multiplex RT-PCR assay for the differential diagnosis of alveolar and Ewing's sarcoma. Am J Pathol 146 (3):626-634
18. Fletcher JA, Kozakewich HP, Hoffer FA (1991) Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue tumors. N Engl J Med 324:436-442
19. Frascella E, Toffolatti L, Rosolen A (1998) Detection of the MyoD1 transcript in rhabdomyosarcoma cell lines and tumor samples by reverse transcription polymerase chain reaction. Am J Pathol 152(2):577-582
20. Gabert J (1999) Detection of recurrent translocations using real time PCR; assessment of the technique for diagnosis and detection of minimal residual disease. Haematologica 84:107-109
21. Gattenloehner S, Dockhorn-Dworniczak B, Leuschner I, Vincent A, Muller-Hermelink HK, Marx A (1999) A comparison of MyoD1 and fetal acetylcholine receptor expression in childhood tumors and normal tissue. J Mol Diagn 1(1):23-31
22. Israeli RS, Miller WH, Su SL, Powell CT, Fair WR, Samadi SD, Huryk RF, DeBlasio A, Edwards ET, Wise GJ (1994) Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells. Comparison of prostate specific membrane antigen and prostate specific antigen-based assay. Cancer Res 54:6306-6310
23. Kelly KM (1996) Minimal disease detection in patients with alveolar rhabdomyosarcoma using a reverse transcription polymerase chain reaction method. Cancer 15:1320-1327
24. Kelly KM (1997) Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma. J Clin Oncol 15(5):1831-1836
25. Kodet R (1989) Rhabdomyosarcoma in childhood. An immunohistochemical analysis with myoglobin, desmin and vimentin. Pathol Res Pract 185:207-213
26. Kullendorff CM, Donner M, Mertens F, Mandahl N (1998) Chromosomal aberrations in a consecutive series of childhood rhabdomyosarcoma. Med Pediatr Oncol 30:156-159
27. Kumar S, Perlman E, Harris CA, Raffeld M, Tsokos M (2000) Myogenin is a specific marker for rhabdomyosarcoma: an immunohistochemical study in paraffin-embedded tissues. Mod Pathol 13:988-993
28. Kushner BH, LaQuaglia MP, Cheung NK, Kramer K, Hamelin AC, Gerald WL, Ladanyi M (1999) Clinically critical impact of molecular genetic studies in pediatric solid tumors. Med Pediatr Oncol 33:530-535
29. Leuschner I, Harms D, Mattke A, Koscieniak E, Treuner J (2001) Rhabdomyosarcoma of the urinary bladder and vagina: clinicopathologic study with emphasis on recurrent disease: a report from the Kiel Pediatric Tumor Registry and the German CWS Study. Am J Surg Pathol 25:856-864
30. Miettinen M, Rapola J (1989) Immunohistochemical spectrum of rhabdomyosarcoma and rhabdomyosarcoma-like tumors. Expression of cytokeratin and 68-kD neurofilament protein. Am J Surg Pathol 13:120-132
31. Miki H, Kobayashi S, Kushida Y, Sasaki M, Haba R, Hirakawa E, Ogura K, Ohmori M (1999) A case of infantile rhabdomyofibrosarcoma with immunohistochemical, electron microscopical, and genetic analyses. Hum Pathol 30(12):1519-1522
32. Mitterbauer G, Zimmer C, Pirc-Danoewinata H, Haas OA, Hojas S, Schwarzinger I, Greinix H, Jager U, Lechner K, Mannhalter C (2000) Monitoring of minimal residual disease in patients with MLL-AF6-positive acute myeloid leukaemia by reverse transcriptase polymerase chain reaction. Br J Haematol 109(3):622-628
33. Newton WA, Gehan EA, Webber BL, Marsden HB, van Unnik AJ, Hamoudi AB, Tsokos MG, Shimada H, Harms D, Schmidt D (1995) Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification - an Intergroup Rhabdomyosarcoma Study. Cancer 75 (6):1073-1085
34. Parham DM (2001) Pathologic classification of rhabdomyosarcomas and correlation with molecular studies. Mod Pathol 14:506-514
35. Parham DM, Webber B, Holt H, Williams WK, Maurer H (1991) Immunohistochemistry of childhood rhabdomyosarcomas and related neoplasms. Results of an Intergroup Rhabdomyosarcoma Study project. Cancer 67:3072-3080
36. Qualman SJ, Bowen J, Parham DM, Brantom PA, Meyer WH (2003) Protocol for the examination of specimens from patients (children and young adults) with rhabdomyosarcoma. Arch Pathol Lab Med 127:1290-1297
37. Rowe D, Gerrard M, Gibbons B, Malpas JS (1987) Two further cases of t(2;13) in alveolar rhabdomyosarcoma indicating a review of the published chromosome breakpoints. Br J Cancer 56:379-380
38. Ruymann FB, Newton WA, Ragab AH, Donaldson HM, Foulkes M (1984) Bone marrow metastases at diagnosis in children and adolescents with rhabdomyosarcoma. Cancer 53:368-373
39. Scrable H, Witte D, Shimada H, Seemayer T, Sheng WW, Soukup S, Koufos A, Houghton P, Lampkin B, Cavenee W (1989) Molecular differential pathology of rhabdomyosarcoma. Genes Chromosomes Cancer 1(1):23-35
40. Stuart ET, Gruss P (1996) PAX: developmental control genes in cell growth and differentiation. Cell Growth Differ 7(3):405-412
41. Thomson B, Hawkins D, Felgenhauer J, Radich J (1999) RT-PCR evaluation of peripheral blood, bone marrow and peripheral blood stem cells in children and adolescents undergoing VACIME chemotherapy for Ewing's sarcoma and alveolar rhabdomyosarcoma. Bone Marrow Transplant 24(5):527-533
42. Tobar A, Avigad S, Zoldan M, Morc C, Goshen Y, Zaizov R (2000) Clinical relevance of molecular diagnosis in childhood rhabdomyosarcoma. Diagn Mol Pathol 9(1):9-13
43. Tobal K, Moore H, Macheta M, Yin JA (2001) Monitoring minimal residual disease and predicting relapse in APL by quantitating PML-RARalpha transcripts with a sensitive competitive RT-PCR method. Leukemia 15(7):1060-1065
44. Tsokos M (1994) The diagnosis and classification of childhood rhabdomyosarcoma. Semin Diagn Pathol 11:26-38
45. Turc-Carel C, Lizard-Nacol S, Justrabo E, Favrot M, Philip T, Tabone E (1986) Consistent chromosomal translocation in alveolar rhabdomyosarcoma. Cancer Genet Cytogenet 19:361-362
46. Wachtel M, Dettling M, Koscielnik E, Stegmaier S, Treuner J, Simon-Klingenstein K, Buhlmann P, Niggli FK, Schafer BW (2004) Gene expression signatures identify rhabdomyosarcoma subtypes and detect a novel t(2;2)(q35;p23) translocation fusing PAX3 to NCOA1. Cancer Res 64(16):5539-5545
47. Wang NP, Marx J, McNutt MA, Rutledge JC, Gown AM (1995) Expression of myogenic regulatory proteins (myogenin and MyoD1) in small blue round cell tumors of childhood. Am J Pathol 147(6):1799-1810
48. Weintraub H, Davis R, Tapscott S, Thayer M, Krause M, Benezra R, Blackwell TK, Turner D, Rupp R, Hollenberg S (1991) The myoD gene family: nodal point during specification of the muscle cell lineage. Science 251(4995):761-766 (Review)
49. Weitz J, Kienle P, Lacroix J, Willeke F, Benner A, Lehnert T, Herfarth C, von Knebel Doeberitz M (1998) Dissemination of tumor cells in patient undergoing surgery for colorectal cancer. Clin Cancer Res 4:343-348